Empagliflozin Reduces The Total Burden Of Cardiovascular Events Including Recurrent Events In The Empa-Reg Outcome TrialD. H. Fitchett,S. E. Inzucchi,C. Wanner,S. D. Anker,S. Pocock,S. Kaspers,O. Johansen,J. T. George,W. Jamal,S. Hantel,S. S. LundCIRCULATION(2021)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要